International Trade Today is a service of Warren Communications News.
Subscriber Login

EAPA Litigation

Under the Enforce and Protect Act, CBP investigates whether a company is evading particular antidumping and countervailing duty orders. Litigation on determinations made under the relatively new statute have centered on due process protections for respondents, CBP's evidentiary basis for its decisions and the interplay of decisions made on the scope of the applicable AD/CVD orders from both CBP and the Commerce Department. The Court of Appeals for the Federal Circuit issued a key decision for all EAPA cases in Royal Brush Manufacturing v. United States, when it found CBP to have violated a respondent's due process protections by failing to provide it with access to the business proprietary information used in the proceeding. 

to
Refine Category Search
Clear Terms

Search Primer

Multi-word term: Place inside quotes to ensure an exact match together (e.g. "China import").

Term list: Separate terms with spaces, not commas or semicolons to find either word (e.g. AD/CVD antidumping).

Acronyms: Use all capital letters (e.g., ACE).

Required term: If a term must be included in any resulting articles, prefix it with a plus sign (e.g., CBP +releases).

Excluded term: If a term should be excluded from any articles being found, prefix it with a minus sign (e.g., -ruling).

Singular form: Use the singular form when doing multi-word terms (e.g. "russian export control" instead of "russian export controls").

Shortest word form: When you have different word forms in a quoted term, include the shortest version if it is the last part of the expression (e.g., "entity list" instead of "entity listing" or "entity listed").

FDA Proposes to Tighten Controls on Some Surgical Mesh
April 29, 2014 by Brian Feito|FDA

The Food and Drug Administration is proposing to reclassify surgical mesh used for transvaginal pelvic organ prolapse repair as high-risk Class III devices, and is also proposing to require premarket approval (here), after finding new health risks associated with the device. The reclassification would only cover surgical mesh for transvaginal prolapse repair, and would not cover surgical mesh used to treat stress urinary incontinence or for abdominal prolapse repair, hernia repair, and other non-urogynecologic indications, said FDA (here). FDA's proposed order would also reclassify urogynecologic surgical mesh instrumentation from Class I into Class II with additional "special controls." Comments are due July 29.

FDA Bans Some Omega-3 Content Claims on Food Labels
April 29, 2014 by Brian Feito|FDA

The Food and Drug Administration on April 28 banned some nutrient content claims in food labeling for certain omega-3 fatty acids. FDA’s final rule prohibits statements on labels that a food is “high in,” “rich in” or an “excellent source of” the omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA). It also restricts similar claims for alpha-linolenic acid (ALA), but doesn’t go as far as to ban all ALA content claims. The final rule takes effect Jan. 1, 2016.

FDA to Hold Public Meeting in June on Harmonization of International Cosmetics Regs
April 25, 2014 by Brian Feito|FDA

The Food and Drug Administration announced a public meeting June 4 in College Park, Md. to get public input and help the agency prepare for a conference on international cooperation on the regulation of cosmetics. In July, FDA will meet with health agencies from Japan, the European Union and Canada to harmonize their regulations. The agenda for FDA’s meeting will be available (here).